HomeAI · summaries
Storia in 7 fonti
What's the deal with peptides? The hyped market under US review
The substances under review -- including BPC-157, TB-500 and Semax -- are among those Joe Biden's administration restricted from compounding, notably over lack of human clinical trial data.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
fortune.com
The FDA’s peptide vote could create telehealth's next multibillion-dollar market | Fortune
As regulators weigh whether pharmacies can legally compound wellness peptides, companies are preparing for a repeat of the GLP-1 boom—only this time with even murkier science.
- ·
forbes.com
FDA’s Review Of Peptides Signals A Growing Public Health Challenge
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.
- ·
cbc.ca
U.S. FDA panel to review 7 peptides amid growing popularity | CBC News
U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry…
- ·
cnn.com
The future of peptides in the US is about to become clearer. Here’s what you should know | CNN
A little-known advisory group to the US Food and Drug Administration will meet this week to mull over whether to ease restrictions on certain peptides. The injectables are popular…
- ·
aljazeera.com
US regulators to weigh controversial peptides backed by RFK Jr
FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.
- ·
iol.co.za
What's the deal with peptides? The hyped market under US review
The substances under review -- including BPC-157, TB-500 and Semax -- are among those Joe Biden's administration restricted from compounding, notably over lack of human clinical…
- ·
thehindu.com
What's the deal with peptides? The hyped market under U.S. review
Explore the controversial rise of peptides, their FDA review, and concerns over safety and clinical evidence in wellness trends.